GENOMIC DNA METHYLATION ASSOCIATED WITH DISEASE PREDICTION

摘要

Embodiments of the disclosure include methods of determining a risk for cancer for an individual. In particular embodiments, the disclosure includes methods of identifying a methylation status for one or more CpG sites, such as the sites of ZFP57, SPATCIL, OR2L-13, VTRNA2-1, DUSP22, HCG4B, and/or PF4.